相关实验视频
Updated: Jul 14, 2025

10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
14.6K
磁力共振成像和氨基酸PET检测全脑瘤负担
Peng Chen1, Matthew L Scarpelli1, Debbie R Healey2
1School of Health Sciences, Purdue University, West Lafayette, IN, United States.
Frontiers in oncology
|October 9, 2023
概括
[18F]流环PET和MRI提供类似的检测大脑瘤负担单独. 结合这两种方法显著提高了瘤检测的灵敏度,突出了综合评估的双重方法的价值.
科学领域:
- 神经瘤学神经瘤学
- 医疗成像医学成像
- 放射化学 放射化学是指辐射化学.
背景情况:
- [18F]流环PET显示了检测MRI遗漏的大脑瘤的潜力.
- 评估整个脑瘤负担需要比较PET和MRI性能.
- 这项研究评估[F]fluciclovine PET和MRI用于脑瘤负担检测.
研究的目的:
- 量化[F]流环PET和MRI在检测整个大脑瘤负担中的性能.
- 为了比较每个模式的敏感性和特异性,单独和组合.
- 为了确定PET和MRI组合是否提供优越的瘤检测与单独相比.
主要方法:
- 在13只大鼠中建立了正位体人类质母细胞瘤异种移植.
- 老鼠接受了MRI (T1和T2加权) 和[F]fluciclovine PET成像.
- 被清除的大脑的ex vivo光成像作为基本真理,所有图像都被共同注册以进行比较.
主要成果:
- [18F]fluciclovine PET灵敏度 (中位数0.67) 与MRI (中位数0.61) 并没有显著不同.
- 联合PET+MRI灵敏度 (中位数为0.86) 显著高于单独的MRI (41%的增加) 或单独的PET (28%的增加).
- 联合PET+MRI的特异性 (中位数为0.91) 低于单独的MRI (6%的减少) 或单独的PET (2%的减少).
结论:
- [18F]流环PET并没有显著改善瘤负担检测比常规MRI在质母细胞瘤外移植.
- 与单个模式相比,PET和MRI联合评估显著提高了检测灵敏度.
- 综合成像方法可能对评估某些脑瘤有价值.
相关概念视频
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Magnetic Resonance Imaging
5.2K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.2K

